Molecular autism · 2026
JUND-driven stress-responsive astrocytes promote neuronal apoptosis via enhanced gap junction signaling in autism spectrum disorder.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Qi, Yin Huamin, Jiang Qi, Qi Yubo, Bai Jieli, Wang Zhendong, Liu Kailai, Sun Ruizhen, Wang Wenhang, Liu Canying, Yan Weishuo, Luo Jin, Duan Lian, Shan Zhiyan
Аннотация
BACKGROUND: Dysregulated stress responses are increasingly implicated in the pathophysiology of autism spectrum disorder (ASD). Astrocytes, which are highly vulnerable to stress, critically support neuronal survival; however, their specific role in ASD remains poorly defined.
METHODS: We analyzed single nucleus RNA sequencing data from postmortem cortices of ASD and control donors. Our analysis included enrichment analysis of astrocyte subpopulations and integrated pySCENIC-based GRN reconstruction, TF profiling, regulon-DEG analysis, and cell-cell communication. Mechanistic studies involved human iPSC-derived astrocytes-neurons co-culture and astrocyte-specific JUND overexpression in mice. Functional and behavioral assessments were performed to evaluate neuronal viability and ASD-relevant phenotypes.
RESULTS: A subpopulation of stress-responsive astrocytes (SRAs) was identified as specifically enriched in ASD, displaying early transcriptional activation and increased abundance. These SRAs showed marked upregulation of both stress-response pathways and distinct reactive signatures. JUND was established as the core transcriptional orchestrator, controlling 23.8% of the dysregulated transcriptome that defines the core stress-responsive signature, including multiple ASD risk genes. JUND overexpression in astrocytes recapitulated the SRAs molecular profile, while astrocyte-specific JUND activation in mouse cortex elicited core ASD-like behaviors. Mechanistically, JUND upregulated the gap junction gene GJA1, enhancing astrocyte-neuron communication and promoting neuronal apoptosis. This pathogenic cascade was rescued by the gap junction inhibitor GAP27.
LIMITATIONS: This study is focused solely on specific brain regions, the generalizability of the JUND-GJA1-GAP axis across diverse ASD subtypes remains to be validated, and the complete activation pathway of JUND signaling within SRAs as well as their interaction mechanisms with other glial cells are not well understood.
CONCLUSIONS: Our findings demonstrate that a specialized astrocyte subpopulation mediates stress-induced dysfunction in ASD via a JUND-GJA1-GAP apoptotic signaling axis, providing a translational anchor for targeting astrocyte-specific pathways in ASD therapy.
METHODS: We analyzed single nucleus RNA sequencing data from postmortem cortices of ASD and control donors. Our analysis included enrichment analysis of astrocyte subpopulations and integrated pySCENIC-based GRN reconstruction, TF profiling, regulon-DEG analysis, and cell-cell communication. Mechanistic studies involved human iPSC-derived astrocytes-neurons co-culture and astrocyte-specific JUND overexpression in mice. Functional and behavioral assessments were performed to evaluate neuronal viability and ASD-relevant phenotypes.
RESULTS: A subpopulation of stress-responsive astrocytes (SRAs) was identified as specifically enriched in ASD, displaying early transcriptional activation and increased abundance. These SRAs showed marked upregulation of both stress-response pathways and distinct reactive signatures. JUND was established as the core transcriptional orchestrator, controlling 23.8% of the dysregulated transcriptome that defines the core stress-responsive signature, including multiple ASD risk genes. JUND overexpression in astrocytes recapitulated the SRAs molecular profile, while astrocyte-specific JUND activation in mouse cortex elicited core ASD-like behaviors. Mechanistically, JUND upregulated the gap junction gene GJA1, enhancing astrocyte-neuron communication and promoting neuronal apoptosis. This pathogenic cascade was rescued by the gap junction inhibitor GAP27.
LIMITATIONS: This study is focused solely on specific brain regions, the generalizability of the JUND-GJA1-GAP axis across diverse ASD subtypes remains to be validated, and the complete activation pathway of JUND signaling within SRAs as well as their interaction mechanisms with other glial cells are not well understood.
CONCLUSIONS: Our findings demonstrate that a specialized astrocyte subpopulation mediates stress-induced dysfunction in ASD via a JUND-GJA1-GAP apoptotic signaling axis, providing a translational anchor for targeting astrocyte-specific pathways in ASD therapy.